Open AccessThe impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma
Author(s) -
Yasuhiro Tsutani,
Masaoki Ito,
Yoshihisa Shimada,
Hiroyuki Ito,
Norihiko Ikeda,
Haruhiko Nakayama,
Morihito Okada
Publication year - 2022
Publication title -
journal of thoracic and cardiovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.458
H-Index - 192
eISSN - 1085-8687
pISSN - 0022-5223
DOI - 10.1016/j.jtcvs.2022.01.025
Subject(s) - medicine , adenocarcinoma , lymphovascular invasion , epidermal growth factor receptor , oncology , chemotherapy , lung cancer , cancer , gastroenterology , metastasis
The aim of this study was to evaluate the role and effect of adjuvant chemotherapy based on epidermal growth factor receptor mutation status in patients with stage I lung adenocarcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom